Open Clinical Trials:
CLINICAL TRIAL 18613
Phase II Study of nab-Paclitaxel in Combination with Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults
Disease Site: Any Site, Ewing's sarcoma, Osteosarcoma, Rhabdomyosarcoma
View Trial DetailsCLINICAL TRIAL 19414
A Phase 2 Study of Talimogene Laherparepvec (T-VEC) and Radiation in Localized Soft Tissue Sarcoma
Disease Site: Soft Tissue
View Trial DetailsCLINICAL TRIAL 19487
A Phase Ib/II Study to Evaluate the Safety, Feasibility and Efficacy of Nivolumab or Nivolumab in Combination with Azacitidine in Patients with Recurrent, Resectable Osteosarcoma
Disease Site: Any Site, Osteosarcoma
View Trial DetailsCLINICAL TRIAL 19580
A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3011 in Patients with Advanced Solid Tumors
Disease Site: Any Site, Sarcoma
View Trial DetailsCLINICAL TRIAL 19776
A Phase 1/2 Dose Escalation and Dose Expansion Study of BA3021 Alone and in Combination with Nivolumab in Patients with Advanced Solid Tumors
Disease Site: Any Site, Bones and Joints, Breast, Esophagus, Larynx, Lung, Other Respiratory and Intrathoracic Organs, Soft Tissue
View Trial DetailsCLINICAL TRIAL 20251
A Phase 2 Single Arm Open-Label Clinical Trial of ADP-A2M4 SPEAR T cells in subjects with Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma (SPEARHEAD 1 Study)
Disease Site: Any Site
View Trial DetailsCLINICAL TRIAL 20339
Evolutionary Inspired Therapy for Newly Diagnosed, Metastatic, Fusion Positive Rhabdomyosarcoma
Disease Site: Bones and Joints, Rhabdomyosarcoma
View Trial DetailsCLINICAL TRIAL 20345
Phase I/II Trial of Pre-Operative Image Guided Intensity Modulated Proton Radiation Therapy (IMPT) or Photon (IMRT) with Simultaneously Integrated Boost to the High Margin for Retroperitoneal Sarcomas
Disease Site: Anal, Colon, Kidney, Other genitourinary, Pancreas, Rectum, Sarcoma
View Trial DetailsCLINICAL TRIAL 20837
Envasarc: A Pivitol Trial of Envafolimab, and Envafolimab in Combination with Ipilimumab, in Patients with Advanced or Metastatic Undifferentiated Pleomorphic Sarcoma or Myxofibrosarcoma Who Have Progressed on Prior Chemotherapy
Disease Site: Bones and Joints, Sarcoma
View Trial DetailsCLINICAL TRIAL 21136
Phase 2 Clinical Trial of Radiomic Habitat-Directed Radiation Dose Escalation for High-Grade Soft Tissue Sarcoma
Disease Site: Soft Tissue
View Trial DetailsCLINICAL TRIAL 21626
A Phase 1, Open-Label, Multicenter Study to Assess Safety, Tolerability, PK, and Efficacy of MK-1084 as Monotherapy and in Combination with Pembrolizumab in Subjects with KRASG12C Mutant Advanced Solid Tumors
Disease Site: Lung
View Trial DetailsCLINICAL TRIAL 22259
(Peak) A Phase 3 Randomized, Open-label, Multicenter Clinical Study of GT9486+Sunitinib vs Sunitinib in Subjects with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
Disease Site: Other Digestive Organ, Small Intestine, Stomach
View Trial DetailsCLINICAL TRIAL 22300
A Phase 2/3 Study to Evaluate the Efficacy and Safety of Unesbulin in Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma
Disease Site: Soft Tissue
View Trial DetailsCLINICAL TRIAL 22258
Impact of Methotrexate Dosing on Acute Graft-Versus-Host Disease Risk in Allogeneic Hematopoietic Cell Transplant Patients
Disease Site: Bones and Joints
View Trial Details